Open seminar April 15th 13-17:
New research strategy and organisation in "Helse Sør-Øst"
The "Samarbeidsorganet Helse Sør-Øst RHF - Universitetet i Oslo" invites to a seminar on Tuesday April 15th at 13-17 in the large auditorium at the Rikshospitalet HF.
The theme of the seminar is: "Research in South-Eastern Norway Regional Health Authority - new strategy and organisation".
Final date for registration: April 10th
The seminar is free and open for all.
The main target group is scientific employees/researchers, research coordinators and people working in research administration and management.
Click here for programme and more information (PDF format, in Norwegian).
From major journals, first or last author from the Institute for Cancer Research
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
Al Outa A, Hicks S, Thambawita V, Andresen S, Enserink JM, Halvorsen P, Riegler MA, Knævelsrud H(2023) CELLULAR, A Cell Autophagy Imaging Dataset Sci Data, 10(1), 806 DOI 10.1038/s41597-023-02687-x, PubMed 37973836
García-Díaz N, Wei Q, Taskén K(2023) Small molecule inhibitors targeting regulatory T cells for cancer treatment Eur J Immunol, e2350448(in press) DOI 10.1002/eji.202350448, PubMed 37937687
Hindi N, Razak A, Rosembaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DSet al.(2023) Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry ESMO Open, 8(6), 102045(in press) DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
Børø S, Thoresen S, Boge Brant S, Helland Å(2023) Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer Acta Oncol, 62(12), 1642-1648 DOI 10.1080/0284186X.2023.2264484, PubMed 37801361
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
